CHUN-JEN LIUJIA-HORNG KAODING-SHINN CHEN2021-09-042021-09-0420060270-9139https://www.scopus.com/inward/record.uri?eid=2-s2.0-33748946083&doi=10.1002%2fhep.21342&partnerID=40&md5=e1c6d94e0b08706e548bbb341cc6f9aehttps://scholars.lib.ntu.edu.tw/handle/123456789/582186[SDGs]SDG3antivirus agent; hepatitis B(e) antigen; nucleotide; chronic liver disease; disease course; genotype; hepatitis B; Hepatitis B virus; Hepatitis C virus; human; letter; liver cell carcinoma; liver cirrhosis; molecular cloning; priority journal; seroconversion; superinfection; treatment outcome; virus genome; virus replication; DNA, Viral; Genotype; Hepatitis B; Hepatitis B virus; Humans; Prevalence; World Healthletter10.1002/hep.21342169416772-s2.0-33748946083